These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Implications of the ADEMEX trial. Mujais S; Vonesh E; Abu-Alfa A Contrib Nephrol; 2003; (140):131-41. PubMed ID: 12800353 [No Abstract] [Full Text] [Related]
14. A change in adequacy standards could create a nightmare: is it necessary? Cahill M Nephrol Nurs J; 2007; 34(6):653-4. PubMed ID: 18203574 [No Abstract] [Full Text] [Related]
15. When to start dialysis: theory, evidence and guidelines. Tattersall J Contrib Nephrol; 2003; (140):176-86. PubMed ID: 12800358 [No Abstract] [Full Text] [Related]
16. Reflections on the optimal dialysis modality distribution: a North American perspective. Mendelssohn DC Nephrol News Issues; 2002 Mar; 16(4):26-30. PubMed ID: 11902059 [No Abstract] [Full Text] [Related]
17. Some bright spots for home dialysis. Neumann ME Nephrol News Issues; 2012 Aug; 26(9):8. PubMed ID: 23252076 [No Abstract] [Full Text] [Related]
18. The value of PD for the elderly. Nissenson AR Nephrol News Issues; 1991 Jan; 5(1):17-8. PubMed ID: 1961263 [No Abstract] [Full Text] [Related]
20. Translating epoetin research into practice: the role of government and the use of scientific evidence. Lazarus JM; Hakim RM Nephrol News Issues; 2006 Dec; 20(13):12, 22. PubMed ID: 17168053 [No Abstract] [Full Text] [Related] [Next] [New Search]